PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (IPSC)-derived cell therapies for autoimmune diseases and cancer, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results